Low plasma ghrelin concentration is an indicator of the metabolic syndrome

Annals of Medicine

Volumn 38, Issue 4, 2006, Pages 274-279

  Ukkola, Olavi ^a   Pöykkö, Seppo M ^a   Antero Kesaniemi Y ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Blood pressure; Ghrelin; Lipids; Metabolic syndrome; Waist circumference

Indexed keywords

BIOLOGICAL MARKER; GHRELIN;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC KIT; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GROUPS BY AGE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; POPULATION RESEARCH; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RATING SCALE; RISK; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; FASTING; FEMALE; GHRELIN; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PEPTIDE HORMONES; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PREVALENCE;

EID: 33745001430     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890600622192     Document Type: Article

References (29)

1. Ferrannini E. Syndrome X. Horm Res. 1993;39(suppl 3):107-11.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
3. Ukkola O, Bouchard C. Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Ann Med. 2001;33:79-90.
4. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 1999;892:146-54.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60.
6. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522.
7. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-9.
8. Schofl C, Horn R, Schill T, Schlosser HW, Muller MJ, Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:4607-10.
9. Bacha F, Arslanian SA. Ghrelin Suppression in Overweight Children: A Manifestation of Insulin Resistance? J Clin Endocrinol Metab. 2005;90:2725-30.
10. Pöykkö SM, Kellokoski E, Horkko S, Kauma H, Kesäniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes. 2003;52:2546-53.
11. Fagerberg B, Hulten LM, Hulthe J. Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study. Metabolism. 2003;52:1460-3.
12. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245:163-74.
13. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-9.
14. Whatmore AJ, Hall CM, Jones J, Westwood M, Clayton PE. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol. 2003;59:649-54.
15. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366:1059-62.
16. Belfiore F, Iannello S. Insulin resistance in obesity: Metabolic mechanisms and measurement methods. Mol Genet Metab. 1998;65:121-8.
17. Bergman RN, Mittelman SD. Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol. 1998;9:205-21.
18. Björntorp P, Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci. 1999;892:297-307.
19. De Courten M, Zimmet P, Hodge A, Collins V, Nicholson M, Staten M, et al. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med. 1997;14:200-8.
20. Kruszynska YT, Mukherjee R, Jow L, Dana S, Paterniti JR, Olefsky JM. Skeletal muscle peroxisome proliferator-activated receptor-gamma expression in obesity and non-insulin-dependent diabetes mellitus. J Clin Invest. 1998;101:543-8.
21. Langenberg C, Bergstrom J, Laughlin GA, Barrett-Connor E. Ghrelin and the Metabolic Syndrome in Older Adults. J Clin Endocrinol Metab. 2005;90:6448-53.
22. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1483-R1487.
23. Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res. 2004;12:180-6.
24. Otto B, Tschop M, Heldwein W, Pfeiffer AF, Diederich S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol. 2004;151:113-7.
25. Ukkola O. Ghrelin and insulin metabolism. Eur J Clin Invest. 2003;33:183-5.
26. Gauna C, Meyler FM, Janssen JA, Delhanty PJ, Abribat T, van Koetsveld P, et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab. 2004;89:5035-42.
27. Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab. 2005;90:1055-60.
28. Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M, et al. The Relationship between Active Ghrelin Levels and Human Obesity Involves Alterations in Resting Energy Expenditure. J Clin Endocrinol Metab. 2004;89:936-9.
29. Ariyasu H, Takaya K, Hosoda H, Iwakura H, Ebihara K, Mori K, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology. 2002;143:3341-50.